Skip commercializes MO/GO, a wearable system that integrates soft and rigid exoskeleton elements into everyday pants to provide mobility support and increase comfort. The technology is designed to deliver roughly 40% energy support to the quadriceps and hamstring while reducing load on knee joints. Skip is positioning the product for daily wear and has partnered with Arc’teryx to launch the first garments, while also using outdoor-gear rentals to collect anonymized usage data. The company is running clinical trials to evaluate MO/GO for conditions including Parkinson’s, though classification as a medical device is expected to take many years. Initial retail launch pricing is around $4,500, which the company acknowledges may limit access for some low-mobility users; Skip hopes FSA coverage and scaled production will lower costs over time. Skip’s technology originated inside Alphabet’s X Labs; founder Catherine Zeland spun the project into an independent startup after Alphabet declined to sell core patents.

Total raised

$6M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2024